Non-Small Cell Lung Cancer | Joeld W Neal, MD, PhD
Research To Practice | Oncology Videos
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | Faculty Presentation 2: Therapeutic Approaches Targeting HER2, MET, BRAF and KRAS G12C — Joel W Neal, MD, PhD
info_outline
Non-Small Cell Lung Cancer | Jessica J Lin, MD
Research To Practice | Oncology Videos
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | Faculty Presentation 1: Therapeutic Approaches Targeting ALK, ROS1, RET, TRK and NRG1 — Jessica J Lin, MD
info_outline
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress
Research To Practice | Oncology Videos
Featuring perspectives from Ms Kathryn M Lyle, Dr Ritu Salani, Ms Jaclyn Shaver and Dr Brian M Slomovitz, including the following topics: Introduction: Overview of Endometrial Cancer (0:00) First-Line Therapy for Advanced or Recurrent Endometrial Cancer (11:01) Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced Endometrial Cancer (39:09) Novel Investigational Strategies for Newly Diagnosed Advanced Endometrial Cancer (1:00:15) Incidence and Management of HER2-Positive Endometrial Cancer (1:17:52)
info_outline
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
Research To Practice | Oncology Videos
Featuring perspectives from Dr Stephen M Ansell and Dr Brian T Hill, including the following topics: Introduction: Bispecific Antibodies in Community Practice (0:00) Diffuse Large B-Cell Lymphoma (7:06) CD19, CD20 or Both? AZD0486 Bispecific Antibody (29:15) Mantle Cell Lymphoma (32:36) Follicular Lymphoma (48:08) CAR T-Cell Therapy for Marginal Zone Lymphoma (57:17)
info_outline
Non-Hodgkin Lymphoma | Stephen M Ansell, MD, PhD
Research To Practice | Oncology Videos
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Non-Hodgkin Lymphoma | Faculty Presentation 2: Other Available and Emerging Novel Therapies for NHL — Stephen M Ansell, MD, PhD
info_outline
Non-Hodgkin Lymphoma | Brian T Hill, MD, PhD
Research To Practice | Oncology Videos
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Non-Hodgkin Lymphoma | Faculty Presentation 1: Current Role of Chimeric Antigen Receptor (CAR) T-Cell Therapy and Bispecific Antibodies in Various Non-Hodgkin Lymphoma (NHL) Subtypes — Brian T Hill, MD, PhD
info_outline
Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances
Research To Practice | Oncology Videos
Featuring perspectives from Dr Ian E Krop and Dr Sara M Tolaney, including the following topics: Introduction: Adjuvant CDK4/6 Inhibition (0:00) HER2-Positive Disease (11:13) PARP Inhibition (27:34) Antibody-Drug Conjugates (34:12) Up-Front Treatment of HR-Positive Metastatic Disease (46:28)
info_outline
Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting
Research To Practice | Oncology Videos
Featuring perspectives from Dr Daniel George, Dr Leonard G Gomella and Dr Evan Y Yu, moderated by Dr George, including the following topics: Introduction (0:00) Current Treatment Landscape for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) — Dr Gomella (3:42) Clinical Implications of and Appropriate Strategies to Identify PTEN Deficiency in Prostate Cancer — Dr Yu (35:37) Emerging Role of AKT Inhibition for mHSPC — Dr George (1:06:18)
info_outline
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
Research To Practice | Oncology Videos
Featuring perspectives from Dr Prithviraj Bose and Dr Andrew T Kuykendall, including the following topics: Systemic Mastocytosis — Dr Bose (0:00) Myelofibrosis — Dr Kuykendall (24:46)
info_outline
Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit
Research To Practice | Oncology Videos
Featuring perspectives from Dr Thomas A Abrams and Dr Ahmed Omar Kaseb, including the following topics: Current Treatment for Advanced Hepatocellular Carcinoma (HCC) — Dr Abrams (0:00) Promising Novel Approaches to HCC Management — Dr Kaseb (33:46)
info_outlineFeaturing a slide presentation and related discussion from Dr Lindsey Roeker, including the following topics:
- Recent clinical updates with standard regimens for chronic lymphocytic leukemia (CLL) (0:00)
- Utility of minimal residual disease-guided treatment intensification after ibrutinib with venetoclax (7:03)
- Major long-term findings from the GLOW study of ibrutinib with venetoclax (10:35)
- Principal findings from the AMPLIFY study of acalabrutinib with venetoclax with or without obinutuzumab (12:28)
- Findings with combined acalabrutinib, venetoclax and obinutuzumab for patients with previously untreated high-risk disease (15:52)
- Early clinical findings with sonrotoclax and zanubrutinib as front-line treatment for CLL (18:12)
- Principal findings from the BRUIN CLL-321 trial of pirtobrutinib for patients who previously received a covalent Bruton tyrosine kinase (BTK) inhibitor (19:38)
- Emerging evidence with pirtobrutinib, venetoclax and obinutuzumab as front-line treatment (22:15)
- Novel strategy combining lisocabtagene maraleucel with ibrutinib for relapsed/refractory (R/R) CLL (24:13)
- Available data with epcoritamab monotherapy for R/R CLL (26:58)
- The emerging pharmacologic class of BTK degraders (29:04)